AiArthritis Advocacy Field Trip: 2026 BMS Policy Forum

AiArthritis' Grassroots Advocacy Manager Vanessa Lathan recently attended Bristol Myers Squibb's (BMS) first policy forum of 2026, which brought together patient leaders, advocates, and policy experts to discuss major healthcare policy issues that affect patients' ability to access and afford care and medications.


Conversations focused on how healthcare policies can create real, lasting improvements for patients - not just changes that look good on paper. Read on to uncover the key takeaways from these conversations.

Where the Healthcare System is Missing the Mark

A central theme was that healthcare reform must lower overall costs and improve patient health outcomes to ensure that patients can access treatments, afford medications, and receive quality care when needed. Speakers emphasized investing in primary care and prevention, which can help people stay healthier while lowering long-term healthcare costs. Another major topic was price transparency, especially when it comes to Pharmacy Benefit Managers (PBMs), drug rebate systems, and what patients ultimately pay out of pocket for medications.


Speakers cautioned that some healthcare policies that look promising on paper do not always yield real savings or improved patient access. That is why transparency, monitoring, and accountability are critical as policies are implemented. Programs like 
340B, which support healthcare providers serving underserved communities, were also discussed as areas where transparency and oversight remain important.


The timeline for new medications (often 7–8 years to reach patients) can
delay timely access to important treatments.


Speakers discussed
biosimilars, medications similar to existing biologic drugs, as a way to help create competition and potentially lower costs, though manufacturing and policy challenges can delay their availability. Strengthening biosimilar manufacturing in the US was identified as an important step forward.


Future advocacy priorities may include:


  • Linking drug pricing policies to improvements in patient health outcomes
  • Supporting personalized care models to address individual patient needs
  • Expanding proven healthcare innovation programs
  • Addressing long-term care challenges as the population ages


Keeping Patients at the Center of Policy

A second discussion focused on the patient perspective and why patient-centered policymaking is essential. Polling shows that healthcare costs are now the number one financial concern for many Americans, even higher than food or other household expenses. In fact, a recent survey found that 77% of patients worry about financial hardship related to healthcare costs more than those who worry about disease symptoms or disease progression. Speakers emphasized that while policymakers often talk about saving money in the healthcare system, those savings do not always reach patients directly.


Other challenges discussed included:


  • Rising insurance premiums and out-of-pocket costs
  • Structural barriers that limit access to copay assistance programs
  • Patients struggling to afford or maintain health insurance
  • Access issues in mental health care, especially when patients cannot find in-network providers 


These issues can make it difficult for
patients to receive the care or medications they need. To better understand these challenges, check out the recent survey conducted by the Patient Inclusion Council, organized by AiArthritis, which explores medication access and affordability across health conditions.


Why Patient Advocacy Matters

Throughout the event, the message was clear: patient voices are essential to shaping healthcare policy. Advocates play a key role in helping policymakers understand real patient experiences. 


Speakers encouraged advocates to engage policymakers earlier and to continue holding them accountable to ensure healthcare policies truly improve affordability and access.


Ultimately, healthcare reform sho
uld improve quality of life for patients and ensure healthcare system savings translate into lower costs, better access, and improved care for the people who need it most.


Drive Change Through Advocacy



Make your voice count—explore how you can drive change in healthcare, research, and policy through patient-powered advocacy. 

Learn More
IV drip bag hanging on a stand in a softly lit hospital room
May 30, 2026
Explore the latest discussion on early treatment for rheumatoid arthritis and what current research reveals about diagnosis, intervention, and long-term patient outcomes.
Woman in a white blazer seated at a vanity, holding a makeup mirror in a softly lit room.
May 30, 2026
Discover the latest research on rheumatoid arthritis, including insights into disease risk, the importance of early treatment, and the connection between RA and lung disease.
Person seated on a chair, clutching a glowing red knee in pain
May 29, 2026
Explore what emerging research is teaching us about difficult-to-treat and poly-refractory rheumatoid arthritis, including the challenges patients face when treatments stop working and the search for more personalized approaches to care.
Older man using a tablet at a desk in a bright home office
May 29, 2026
Learn about VEXAS syndrome, a newly identified inflammatory condition linked to immune system dysfunction, and why greater awareness may help patients with complex or overlapping AiArthritis disease symptoms find answers sooner.
More Posts